A quick overview to the early phase clinical trials of Simtuzumab®: Are we loosing the most promising anti-fibrotic product?. (October 2017)

Record Type:
Journal Article
Title:
A quick overview to the early phase clinical trials of Simtuzumab®: Are we loosing the most promising anti-fibrotic product?. (October 2017)
Main Title:
A quick overview to the early phase clinical trials of Simtuzumab®: Are we loosing the most promising anti-fibrotic product?
Authors:
Altinbas, Akif
Abstract:
Is Part Of:
Medical hypotheses. Volume 108(2017)
Journal:
Medical hypotheses
Issue:
Volume 108(2017)
Issue Display:
Volume 108, Issue 2017 (2017)
Year:
2017
Volume:
108
Issue:
2017
Issue Sort Value:
2017-0108-2017-0000
Page Start:
159
Page End:
160
Publication Date:
2017-10
Subjects:
LOXL-2 Lysil oxidase like protein 2 -- HCV hepatitis B virus -- HBV hepatitis B virus -- NASH non-alcoholic steatohepatitis
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Medicine
Periodicals
610
Journal URLs:
http://www.medical-hypotheses.com ↗
http://www.harcourt-international.com/journals ↗
http://www.sciencedirect.com/science/journal/03069877 ↗
http://www.idealibrary.com/cgi-bin/links/toc/mehy ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0306-9877;screen=info;ECOIP ↗
DOI:
10.1016/j.mehy.2017.09.008 ↗
Languages:
English
ISSNs:
0306-9877
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5527.530000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
5044.xml